Dr. Orest Lastow, Iconovo AB - Qepler Summits And Conferences

Dr. Orest Lastow

CEO
Iconovo AB
Malmo, Sweden
Iconovo AB

Dr. Orest Lastow is the co-founder and CEO of Iconovo AB.

He is responsible for the development of Iconovo’s inhalation device platforms and formulations and has over 40 patents and patent applications. He is also the founder and previous CEO of Medicon Valley Inhalation Consortium, MVIC AB.

Before that Orest was with AstraZeneca for over 15 years.

Orest received a M.Sc. in Engineering Physics and a Licentiate of Engineering degree in Aerosol Science from Lund University. He has also a Ph.D. in electrohydrodynamic atomization from Brunel University. His expertise is in device development, electrostatics, Computational Fluid Dynamics (CFD), aerosol science and inhalation technology. He is the author behind a textbook on EHD atomization, several journal publications and book contributions.

He is frequently invited to speak at conferences and teaches aerosol drug delivery at Lund University, Copenhagen University and Shenyang University.

Orest is a co-author of the Aerosol drug delivery device design verification standard (ISO 20072).

Related Sessions:

Inhaled Drug Delivery
Summit 2019

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 27 Feb 2019
  • Berlin, DE
  • Pharma
Day 1: Wednesday, 27 February 2019
BLOCK: INNOVATIVE TECHNOLOGIES.
CASE STUDY: Development of a generic triple combination product – hurdles and opportunities.
  • Why triple combinations to treat asthma and COPD? What are the clinical benefits?
  • API combinations on the market or in the clinical pipeline
  • Formulation challenges with triple combination
  • Special device requirements and availability
  • Hurdles and opportunities for generic companies
View Details